During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst rati

Bristol Myers Squibb's Growth Portfolio and pipeline support momentum, but generic headwinds and rec

Drugmaker Bristol Myers Squibb on Monday said it will spend about $2.3 billion to build a new manufa

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Advances U.S. Manufacturing Inv

Surging oil prices, a CPI spike not seen in three years, and Treasury yields at levels last touched

Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about th

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS t

There are "no discussions" ongoing between AstraZeneca and ​Bristol Myers Squibb over a potential ‌d

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASD

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Bristol Myers (BMY) is at a 52-week high, but can investors hope for more gains in the future? We ta

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in

Holz framed the logic bluntly. “If you take these two companies and you slash expenses, that would b

As per a media report over the weekend, AstraZeneca Plc (NYSE:AZN) and Bristol Myers Squibb Co. (NYS

AstraZeneca and Bristol Myers reportedly discuss a $400 billion merger as analyst assesses valuation

Crude tumbles nearly 6% after Trump cancels a strike on Iran, lifting the S&P 500 1.3% and the R

Falling Oil Please click here for an enlarged chart of United States Oil ETF (NYSE:USO). N

Bristol-Myers Squibb (BMY) stock is declining this morning, reversing its premarket gains as Wall St

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a co

Geopolitical relief triggered a sharp selloff in oil and a Treasury retreat, handing bulls an openin

Bristol Myers Squibb and AstraZeneca in talks for a $400B mega-merger, potentially creating the worl

Jim Cramer senses a 'fake out' in the rumored $400B AstraZeneca and Bristol Myers Squibb meg

Stock futures are pointing to a higher open to kick off August trading as investors look ahead to a

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in t

U.S. stock futures higher, AstraZeneca dips on merger talks, Apple down 7.4%, other stocks moving lo

Atkore Inc (ATKR) shares rise on strong Q3 results and acquisition by Prysmian for $95.00 per share.

AstraZeneca in talks to merge with Bristol Myers Squibb, creating $400B pharma giant, while talks on

FDA advisory panel backed Replimune's RP1 melanoma data ahead of the agency's August 2 decis

US stocks gain, Dow up 300 points as tech shares surge 5.3%, Bristol-Myers Squibb beats expectation

The CNN Money Fear and Greed index showed a sharp decline in market sentiment as stocks fell and oil

U.S. stock futures trading higher, focus on Apple, Microsoft, Amazon earnings. Meta posts mixed resu

Apple Inc., Mastercard Inc., and The Southern Company all reported earnings, with the options market

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug disc

Approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with es

FDA accepts Bristol Myers Squibb's mezigdomide NDA for relapsed multiple myeloma, with a PDUFA d

Application based on results from SUCCESSOR-2 trial showing oral CELMoD mezigdomide in combination w

The Nasdaq 100 has tripled since 2020, but 10 mega-caps still trade below pre-Covid levels. Who'

Elicio shares complete response data for ELI-002 7P in KRAS pancreatic cancer and plans combination

Takeda's psoriasis drug zasocitinib outperformed Bristol Myers Squibb's Sotyktu in a Phase 3

In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-

In times of market turbulence, investors turn to dividend-yielding stocks. Benzinga provides real-ti

Supreme Court lets Medicare drug price negotiations continue, rejecting pharma industry challenges t

The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Med

Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook

Trump, in January, said "inflation has been defeated." Wall Street is now bracing for a 0.9%